4.7 Article

Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model

Journal

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 11, Pages 27191-27207

Publisher

MDPI
DOI: 10.3390/ijms161126016

Keywords

NSCLC; imatinib; vitamin D analogs

Funding

  1. Foundation for the Development of Pharmaceutical Sciences, Poland [9/FB/2004]
  2. Polish National Science Center [2013/09/N/NZ4/01720]
  3. Wroclaw Centre of Biotechnology within a program of the Leading National Research Centre

Ask authors/readers for more resources

In previous papers, we presented data on studies on the anticancer activity of the vitamin D-3 analogs, named PRI-2191 and PRI-2205, in different cancer models. In this study, we showed the improved antiproliferative activity of a combination of imatinib mesylate (Gleevec, GV) and cytostatic agents in in vitro studies, when used with a third compound, namely PRI-2191, in an A549 human lung cancer model. Furthermore, we analyzed the influence of both PRI-2191, as well as PRI-2205 on the anticancer activity of GV in mice bearing A549 tumors. The route of PRI-2191 analog administration showed a significant impact on the outcome of GV treatment: subcutaneous injection was more efficient and less toxic than oral gavage. Moreover, both vitamin D compounds increased the anticancer activity of GV; however, they might also potentiate some adverse effects. We also evaluated in tumor tissue the expression of VEGF, PDGF-BB, vitamin D receptor, CYP27B1, CYP24, p53 and Bcl-2, as well as PDGF receptors: and . We observed the upregulation of p53 expression and the downregulation of Bcl-2, as well as VEGF in A549 tumors as a result of the tested treatment. However, vitamin D analogs did not significantly influence the expression of these proteins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia

Piotr Lacina, Aleksandra Butrym, Eliza Turlej, Martyna Stachowicz-Suhs, Joanna Wietrzyk, Grzegorz Mazur, Katarzyna Bogunia-Kubik

Summary: This study confirms the importance of BSG/MCT1 in AML, and suggests that soluble BSG and BSG/MCT1 genetic variants may act as potential AML biomarkers.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Oncology

Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D

Justyna Joanna Gleba, Dagmara Klopotowska, Joanna Banach, Eliza Turlej, Karolina Anna Mielko, Katarzyna Gebura, Katarzyna Bogunia-Kubik, Andrzej Kutner, Joanna Wietrzyk

Summary: This study aimed to determine the use of active forms of vitamin D-3, calcitriol and tacalcitol, as anticancer drugs for leukemias and lymphomas, and to identify the molecular factors responsible for cell sensitivity to these agents. The results suggest that VDR gene receptor polymorphism may be associated with the response to these drugs in cancer therapy.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Micro-RNAs in Response to Active Forms of Vitamin D3 in Human Leukemia and Lymphoma Cells

Justyna Joanna Gleba, Dagmara Klopotowska, Joanna Banach, Karolina Anna Mielko, Eliza Turlej, Magdalena Maciejewska, Andrzej Kutner, Joanna Wietrzyk

Summary: Non-coding micro-RNAs (miRNAs) regulate cell growth and proliferation and play a role in the response of cancer cells to drug treatment. This study investigated the correlation between selected miRNAs and regulated proteins in leukemia and lymphoma cells in response to two active forms of vitamin D-3. The results showed a correlation between the levels of certain miRNAs (most notably miR-27b and miR-125b) and the levels of proteins involved in cell regulation, suggesting their potential role in the anticancer activity of vitamin D-3.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) - A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis

Patrycja Koszalka, Barbara Kutryb-Zajac, Paulina Mierzejewska, Marta Tomczyk, Joanna Wietrzyk, Pawel K. Serafin, Ryszard T. Smolenski, Ewa M. Slominska

Summary: This study found that the metabolic product 4PYR, which accumulates in the blood of cancer patients, promotes lung metastasis through multiple mechanisms. In vivo studies showed that 4PYR did not affect primary tumor growth but facilitated lung metastasis. In vitro studies demonstrated that 4PYR affected extracellular adenine nucleotide metabolism and intracellular energy status, leading to increased permeability of lung ECs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Relationship between Telomere Length, TERT Genetic Variability and TERT, TP53, SP1, MYC Gene Co-Expression in the Clinicopathological Profile of Breast Cancer

Marta Dratwa, Barbara Wysoczanska, Wioletta Brankiewicz, Martyna Stachowicz-Suhs, Joanna Wietrzyk, Rafal Matkowski, Marcin Ekiert, Jolanta Szelachowska, Adam Maciejczyk, Mariusz Szajewski, Maciej Baginski, Katarzyna Bogunia-Kubik

Summary: This study investigated the molecular mechanisms of TERT upregulation in breast cancer, including genetic variability and telomere length, as well as the expression of TERT, MYC, TP53, and SP1 genes in BC patients and BC organoids. Results showed correlations between TERT genotypes, TP53 expression, and telomere length, suggesting TERT genetic variability may serve as potential biomarkers for breast cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

Combined anticancer therapy with imidazoacridinone analogue C-1305 and paclitaxel in human lung and colon cancer xenografts-Modulation of tumour angiogenesis

Marta Switalska, Beata Filip-Psurska, Magdalena Milczarek, Mateusz Psurski, Adrianna Moszynska, Aleksandra M. Dabrowska, Malgorzata Gawronska, Karol Krzyminski, Maciej Baginski, Rafal Bartoszewski, Joanna Wietrzyk

Summary: The combined treatment of C-1305 and PTX showed anticancer activity and improved tumor blood perfusion in in vivo studies. It resulted in increased level of CCL2 and decreased level of PDGF. Furthermore, the treatment modulated the levels of certain angiogenesis-related cytokines.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)

Review Oncology

Vitamin D, Th17 Lymphocytes, and Breast Cancer

Beata Filip-Psurska, Honorata Zachary, Aleksandra Strzykalska, Joanna Wietrzyk

Summary: This article reviews the impact of vitamin D-3 on Th17 cells in breast cancer, finding that its effectiveness depends on factors such as age, menopausal status, and obesity. Moreover, the role of vitamin D-3 in breast cancer development is controversial. Due to the scarcity of scientific data on Th17 lymphocytes and breast cancer, further clinical trials and studies are needed to assess the importance of vitamin D in breast cancer.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers

Vaikunthavasan Thiruchenthooran, Marta Switalska, Lorena Bonilla, Marta Espina, Maria Luisa Garcia, Joanna Wietrzyk, Elena Sanchez-Lopez, Anna Gliszczynska

Summary: The aim of this study was to design innovative nanostructured lipid carriers (NLCs) to deliver dexibuprofen (DXI) as an antiproliferative therapy against tumoral processes and overcome its side effects. Through optimization of the formulation, DXI-NLCs with small particle size, high entrapment efficiency, and slow drug release were obtained. The DXI-NLCs showed the highest activity against breast cancer cells, providing early preclinical evidence for the treatment of breast cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Analytical

Microfluidic-Assisted Human Cancer Cells Culturing Platform for Space Biology Applications

Agnieszka Krakos (Podwin), Joanna Jarosz, Patrycja Sniadek, Mateusz Psurski, Adrianna Graja, Marcin Bialas, Ewa Oliszewska, Joanna Wietrzyk, Rafal Walczak, Jan Dziuban

Summary: This paper presents a lab-on-chip platform for the long-term cultivation of human cancer cells, which meets the requirements of CubeSat biological missions. Cancer cell lines UM-UC-3 and RT 112 were cultured on the chip for up to 50 days, showing successful results and providing a basis for further testing in terrestrial and space conditions.

SENSORS (2022)

Article Biochemistry & Molecular Biology

Cholinesterases Inhibition, Anticancer and Antioxidant Activity of Novel Benzoxazole and Naphthoxazole Analogs

Alicja Skrzypek, Monika Karpinska, Malgorzata Juszczak, Aneta Grabarska, Joanna Wietrzyk, Elzbieta Krajewska-Kulak, Marek Studzinski, Tadeusz Paszko, Joanna Matysiak

Summary: Benzoxazole and naphthoxazole fused systems, functionalized by the 2,4-dihydroxyphenyl moiety, showed potential activity in inhibiting AChE, anticancer effects, and antioxidant properties. Naphtho[1,2-d][1,3]oxazoles exhibited higher antiproliferative activity against human cancer cell lines compared to benzoxazoles, with one analog showing no toxicity to normal cells.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Studies on the Complexation of Platinum(II) by Some 4-Nitroisoxazoles and Testing the Cytotoxic Activity of the Resulting Complexes

Henryk Mastalarz, Agnieszka Mastalarz, Joanna Wietrzyk, Magdalena Milczarek, Andrzej Kochel, Andrzej Regiec

Summary: Two new platinum(II) complexes (1 and 2) were synthesized and characterized using various analytical techniques. The cytotoxicity of these complexes against different cancer cell lines was evaluated, and their cellular platinum uptake and stability were determined. Complex 2 showed higher cytotoxic activity compared to cisplatin, while complex 1 exhibited varying activity against different cancer cell lines.

MOLECULES (2023)

Article Pharmacology & Pharmacy

Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy

Gerard Esteruelas, Eliana B. Souto, Marta Espina, Maria Luisa Garcia, Marta Switalska, Joanna Wietrzyk, Anna Gliszczynska, Elena Sanchez-Lopez

Summary: Cancer is a leading cause of death worldwide, but there is still a need for an effective treatment with minimal adverse effects. Diclofenac, a non-steroidal anti-inflammatory drug, has shown promise as an antitumoral agent, but its prolonged use can lead to adverse effects. In this study, biodegradable polymeric nanoparticles were used to deliver diclofenac in a controlled manner, resulting in prolonged release and demonstrating antitumoral effects without cytotoxicity to non-tumoral cells.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Prenylated Flavonoids with Selective Toxicity against Human Cancers

Tomasz Tronina, Agnieszka Bartmanska, Jaroslaw Poplonski, Magdalena Rychlicka, Sandra Sordon, Beata Filip-Psurska, Magdalena Milczarek, Joanna Wietrzyk, Ewa Huszcza

Summary: The antiproliferative activity of xanthohumol and its aurone derivative was investigated against ten human cancer cell lines and two normal cell lines. Both flavonoids showed potent to moderate anticancer activity against most tested cancer cell lines, including drug-resistant ones, while the reference drug cisplatin acted non-selectively. The findings suggest that these flavonoids have strong potential as candidates for further studies in the search for effective anticancer drugs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil's Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer

Malgorzata Milczarek, Tomasz Cierpial, Piotr Kielbasinski, Milena Malecka-Gieldowska, Marta Switalska, Joanna Wietrzyk, Maciej Mazur, Katarzyna Wiktorska

Summary: The combination of 5-fluorouracil and ISC has synergistic effects on triple-negative breast cancer, leading to enhanced antiproliferative effects and safety.

MOLECULES (2023)

No Data Available